Results 101 to 110 of about 3,182,211 (266)

Era of direct acting anti-viral agents for the treatment of hepatitis C. [PDF]

open access: yes, 2018
Hepatitis C infection is universal and the most common indication of liver transplantation in the United States. The period of less effective interferon therapy with intolerable side effects has gone.
Ahmed, Monjur
core   +1 more source

Antivir Ther [PDF]

open access: yes
Approximately 4.1 million Americans have been infected with HCV and 45-85% of chronically infected persons are unaware of their status. Rapid anti-HCV assays can assist and expedite the identification of those unaware of their infection.

core  

HBV/HCV co-infection in Iran: A seroepidemiological based study

open access: yes, 2006
The aim of this study was to determine the seroprevalence of HCV in HBsAg positive subjects. In a population based single stage cluster sampling in Golestan province of Iran, 139 HBsAg positive subjects were detected and enrolled in the study.
Abdolahi, N.   +12 more
core   +1 more source

Prevalence of Hepatitis C among Multi-transfused Thalassaemic Patients in Oman: Single centre experience

open access: yesSultan Qaboos University Medical Journal, 2015
Objectives: Regular blood transfusions are essential for patients with thalassaemia major. However, infections with hepatotropic viruses remain a major concern. The objective of this study was to evaluate the prevalence and characteristics of hepatitis C
Khalid Al-Naamani   +4 more
doaj   +2 more sources

PERSPECTIVES OF TREATMENT OF TERMINAL LIVER DISEASE IN CHRONIC HCV-INFECTION

open access: yesСеченовский вестник, 2010
Aim. Assessment of role of HBV viral proteins in liver disease progression in chronic HCV-infected patients.Methods. 2934 patients were included into the study, in whom serological markers of HBV- and HCV-infection were evaluated.
E. N. German   +4 more
doaj  

Uji Saring Antigen dan Antibodi Hepatitis C Virus pada Darah Donor [PDF]

open access: yes, 2015
According to the data from Central Blood Transfusion Unit, the prevalence of hepatitis C virus (HCV) in blood donors in Indonesia and especially Jakarta in 2012 were 0.39% and 0.36% respectively.
Ibrahim, F. (Fera)   +3 more
core  

Home - About - Disclaimer - Privacy